Here's the live share price of Panacea Biotec along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Panacea Biotec has gained 8.54% CAGR. Over the past year, the corresponding return has been -23.76%.
Panacea Biotec’s current P/E of -292.05x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Panacea Biotec | 4.24 | -8.79 | -22.50 | -19.35 | -23.76 | 35.89 | 8.54 |
| Sun Pharmaceutical Industries | -3.37 | -0.78 | 5.89 | 5.97 | -3.02 | 20.90 | 24.86 |
| Divi's Laboratories | -0.68 | -1.34 | 4.69 | -2.29 | 9.24 | 24.04 | 10.77 |
| Torrent Pharmaceuticals | -0.94 | -0.73 | 5.57 | 16.70 | 11.39 | 33.11 | 22.12 |
| Cipla | -0.96 | -1.13 | -5.12 | -0.05 | 1.73 | 10.95 | 13.53 |
| Dr. Reddy's Laboratories | 0.52 | 2.90 | -3.24 | -2.53 | 0.36 | 13.31 | 4.11 |
| Lupin | 1.86 | 3.51 | 3.57 | 8.46 | 0.97 | 42.74 | 16.86 |
| Zydus Lifesciences | -1.35 | -1.97 | -13.16 | -4.99 | -7.06 | 30.52 | 13.82 |
| Mankind Pharma | -1.46 | -4.00 | -19.07 | -9.31 | -23.90 | 14.45 | 8.44 |
| Aurobindo Pharma | 3.28 | -2.30 | 7.31 | 9.39 | -2.95 | 40.38 | 6.45 |
| Alkem Laboratories | -2.10 | -3.58 | 0.51 | 14.62 | 0.39 | 22.43 | 13.24 |
| Abbott India | -1.27 | -6.14 | -9.87 | -11.54 | -0.94 | 10.11 | 11.52 |
| Glenmark Pharmaceuticals | -0.05 | 6.17 | -7.33 | 17.78 | 28.29 | 67.47 | 30.53 |
| Laurus Labs | -0.22 | 0.98 | 10.07 | 53.14 | 79.08 | 37.85 | 23.47 |
| Biocon | 2.56 | -7.19 | 6.23 | 14.37 | 12.46 | 14.16 | -3.66 |
| GlaxoSmithKline Pharmaceuticals | -3.21 | 2.09 | -7.63 | -22.68 | 8.77 | 24.02 | 9.53 |
| Anthem Biosciences | -1.47 | 2.40 | -21.05 | -7.58 | -7.58 | -2.59 | -1.56 |
| Ipca Laboratories | -3.52 | -0.35 | 6.01 | 4.11 | -6.44 | 18.41 | 4.91 |
| Ajanta Pharma | -1.71 | 5.89 | 2.29 | 0.97 | -9.93 | 30.31 | 18.84 |
| J B Chemicals & Pharmaceuticals | -1.37 | -0.53 | 5.82 | 4.08 | -3.60 | 20.22 | 27.44 |
Over the last one year, Panacea Biotec has declined 23.76% compared to peers like Sun Pharmaceutical Industries (-3.02%), Divi's Laboratories (9.24%), Torrent Pharmaceuticals (11.39%). From a 5 year perspective, Panacea Biotec has underperformed peers relative to Sun Pharmaceutical Industries (24.86%) and Divi's Laboratories (10.77%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 344.81 | 350.01 |
| 10 | 344.33 | 349.5 |
| 20 | 353.33 | 358.01 |
| 50 | 398.45 | 382.32 |
| 100 | 406.78 | 400.37 |
| 200 | 429.03 | 400.72 |
In the latest quarter, Panacea Biotec remained same as its previous close in promoter holding, while DII stake increased to 1.80%, FII holding rose to 1.06%, and public shareholding moved down to 24.65% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Dec 16, 2025, 12:25 AM IST | Panacea Biotec L - Authorization Of Key Managerial Personnel For The Purpose Of Determining Materiality Of An Event Or Inform |
| Dec 16, 2025, 12:14 AM IST | Panacea Biotec L - Appointment of Company Secretary and Compliance Officer |
| Dec 16, 2025, 12:09 AM IST | Panacea Biotec L - Announcement under Regulation 30 (LODR)-Cessation |
| Dec 16, 2025, 12:04 AM IST | Panacea Biotec L - Announcement under Regulation 30 (LODR)-Change in Management |
| Dec 04, 2025, 8:41 PM IST | Panacea Biotec L - Details Of Shares Dematerialized During November 2025Under Regulation 74(5) Of The SEBI (Depositories |
Panacea Biotec Ltd. is a Public Limited Listed company incorporated on 02/02/1984 and has its registered office in the State of Punjab, India. Company's Corporate Identification Number(CIN) is L33117PB1984PLC022350 and registration number is 022350. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 309.86 Cr. and Equity Capital is Rs. 6.13 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Panacea Biotec is ₹345.20 as on Dec 18, 2025.
The Panacea Biotec is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Panacea Biotec is ₹2,114.38 Cr as on Dec 18, 2025.
Today’s highest and lowest price of Panacea Biotec are ₹360.70 and ₹341.00.
The 52-week high/low is the highest and lowest price at which Panacea Biotec stock has traded in the past 52-week or nearly a year. The 52-week high of Panacea Biotec is ₹581.00 and 52-week low of Panacea Biotec is ₹282.15 as on Dec 18, 2025.
The Panacea Biotec has shown returns of 0.57% over the past day, -8.79% for the past month, -22.5% over 3 months, -23.76% over 1 year, 35.89% across 3 years, and 8.54% over 5 years.
P/E ratio of and PB ratio of Panacea Biotec are -292.05 and 2.60 on Dec 18, 2025. While the company gives a dividend yield of 0.00 per annum.